Latest Financial Results

Q2 2016

Quarter Ended Jun 30, 2016

Latest 10-K

View 10-K

Stock Information

Cardax, Inc.

OTCQB: CDXI

Price

Change

Volume

52 week Low/High

Day Low/High

Company Overview

Cardax is a life sciences company that devotes substantially all of its efforts to developing safe anti-inflammatory dietary supplements and drugs. Cardax is initially focusing on astaxanthin, which is a powerful and safe naturally occurring anti-inflammatory without the side effects of currently marketed anti-inflammatories. The safety and efficacy of Cardax's products have not been directly evaluated in clinical trials or confirmed by the FDA.

Contact Information

Investor Relations
Cardax, Inc.
T: (808) 457-1400
investors@cardaxpharma.com

Transfer Agent
VStock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598